Quick Answer
OCULAR THERAPEUTIX, INC reported Earnings Per Share Diluted of $1.42 (loss) per share for the year ending 2025.
- OCULAR THERAPEUTIX, INC showed a decrease of -16.4% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from OCULAR THERAPEUTIX, INC's annual report (Form 10-K), filed with the SEC on February 5, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: $0.40 (loss) per share | Q3 2018: $0.38 (loss) per share | Q1 2019: $0.45 (loss) per share | Q3 2019: $0.45 (loss) per share | Q1 2020: $0.41 (loss) per share | Q2 2020: $0.64 (loss) per share | Q3 2020: $0.21 (loss) per share | Q1 2021: $0.24 (loss) per share | Q2 2021: $0.25 (loss) per share | Q3 2021: $0.23 (loss) per share | Q1 2022: $0.22 (loss) per share | Q2 2022: $0.25 (loss) per share | Q3 2022: $0.31 (loss) per share | Q1 2023: $0.39 (loss) per share | Q2 2023: $0.26 (loss) per share | Q3 2023: $0.25 (loss) per share | Q1 2024: $0.49 (loss) per share | Q2 2024: $0.26 (loss) per share | Q3 2024: $0.22 (loss) per share | Q1 2025: $0.38 (loss) per share | Q2 2025: $0.39 (loss) per share | Q3 2025: $0.38 (loss) per share.
- Over the full 7 years of available data (2019 to 2025), OCULAR THERAPEUTIX, INC's Earnings Per Share Diluted has grown by 25.7%.
- Historical annual values: Fiscal year 2025: $1.42 (loss) per share | Fiscal year 2024: $1.22 (loss) per share | Fiscal year 2023: $1.02 (loss) per share | Fiscal year 2022: $0.97 (loss) per share | Fiscal year 2021: $0.98 (loss) per share | Fiscal year 2020: $2.56 (loss) per share | Fiscal year 2019: $1.91 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: